Biblio

Author Title [ Type(Desc)] Year
Filters: Author is van Laar, Jacob M  [Clear All Filters]
Journal Article
van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EWA, Vonk MC, Schattenberg AV, et al. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial. JAMA. 2014;311(24):2490-2498.
van Laar JM, Farge D, Tyndall A. Cardiac Assessment Before Stem Cell Transplantation for Systemic Sclerosis-Reply. JAMA. 2014;312(17):1803-1804.
van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Radstake TRD, Verhaar MC, van Laar JM. Cellular Therapies in Systemic Sclerosis: Recent Progress. Curr Rheumatol Rep. 2016;18(2):12.
Spierings J, van Rhijn-Brouwer FCC, van Laar JM. Hematopoietic stem-cell transplantation in systemic sclerosis: an update. Curr Opin Rheumatol. 2018.
Spierings J, Nihtyanova SI, Derrett-Smith E, Clark KEN, van Laar JM, Ong V, Denton CP. Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2021.
van Rhijn-Brouwer FCC, Spierings J, van Rhenen A, Kuball J, van Laar JM. Second autologous haematopoietic stem cell transplantation in systemic sclerosis-a case report. Rheumatology (Oxford). 2019.
Sharif MO, Leavis HL, van Paassen P, van Rhenen A, Timmermans SAMEG, Ton E, van Laar JM, Spierings J. Severe thrombotic microangiopathy after autologous stem cell transplantation in systemic sclerosis: a case report. Rheumatology (Oxford). 2021.